Unity Biotechnology, Inc.·4

Jan 7, 4:35 PM ET

Grossi Federico 4

4 · Unity Biotechnology, Inc. · Filed Jan 7, 2025

Insider Transaction Report

Form 4
Period: 2025-01-06
Grossi Federico
Chief Medical Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2025-01-06+150,000150,000 total
    Exercise: $1.78Exp: 2035-01-05Common Stock (150,000 underlying)
Footnotes (1)
  • [F1]The underlying shares vest and become exercisable pursuant to the following schedule: 1/48th of the shares subject to the option vest in successive, equal monthly installments on each monthly anniversary of the Vesting Commencement Date of January 1, 2025, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date.

Documents

1 file
  • 4
    ownership.xmlPrimary

    4